Longboard Pharmaceuticals Inc (NASDAQ:LBPH) People

Longboard Pharmaceuticals Inc

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Paul Sekhri
Other companies: Apnimed, Inc. (Director · Since at least Jul 30, 2026); vTv Therapeutics Inc. (Chairman of the Board, President and Chief Executive Officer · Since at least Aug 1, 2022); Veeva Systems Inc. (Director · Since at least Jun 22, 2016); Axcella Health Inc (Director · May 19, 2022 – May 19, 2022 · Past); BiomX Inc. (Director · Oct 2, 2020 – Jul 28, 2021 · Past); Enumeral Biomedical Holdings Inc (Director · Dec 9, 2016 – Dec 9, 2016 · Past); Alpine Immune Sciences Inc (Director · Sep 12, 2016 – Jan 2, 2020 · Past)
Director · Mar 11, 2021 – Dec 2, 2024 · Past
Brandi Roberts
Other companies: Definium Therapeutics, Inc. (Chief Financial Officer · Since at least Jun 2, 2025); TFF Pharmaceuticals Inc (Director · Mar 25, 2022 – Jul 3, 2024 · Past); Lineage Cell Therapeutics, Inc. (CFO & SVP Finance · Jan 7, 2019 – Mar 17, 2020 · Past); Savara, Inc. (Chief Financial Officer & SVP · Jun 19, 2013 – Jan 20, 2017 · Past)
Executive VP and CFO · Mar 11, 2021 – Dec 2, 2024 · Past
Kevin Lind
Other companies: Apnimed, Inc. (Chief Executive Officer · Since at least Jul 30, 2026); Avalo Therapeutics, Inc. (Director · Since at least Sep 22, 2025); Arena Pharmaceuticals Inc (Executive VP and CFO · Jun 15, 2016 – Mar 1, 2020 · Past)
President and CEO, Director · Mar 11, 2021 – Dec 2, 2024 · Past
Vincent Aurentz
Other companies: Inhibikase Therapeutics, Inc. (Director · Since at least Feb 21, 2025); Arena Pharmaceuticals Inc (Executive VP and CBO · Aug 15, 2016 – Mar 11, 2022 · Past); EPIRUS Biopharmaceuticals Inc (Chief Business Officer · Nov 9, 2015 – May 27, 2016 · Past)
Director · Mar 11, 2021 – Dec 2, 2024 · Past
Casey Lynch
Other companies: Quince Therapeutics, Inc. (Chief Executive Officer, Director · May 8, 2019 – Jan 3, 2022 · Past)
Director · Mar 11, 2021 – Dec 2, 2024 · Past
Jane TillerDirector · Nov 15, 2021 – May 25, 2023 · Past
Philip PereraCMO · Mar 11, 2021 – Feb 9, 2022 · Past